Why BPC 157 Peptide Claims Need More Evidence

Original Title

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Scientists are arguing about whether a peptide called BPC 157 is safe and effective. One group says it helps with healing and has no side effects. Another group points out that almost all research comes from one lab, studies only use one tiny dose, and nobody has proven it actually works in humans.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Toxicity 'study' used doses equivalent to only 46-60mg for a mouse

Researchers claim BPC 157 is safe at 2 g/kg, but this is only 46-60mg for a 23-30g mouse - a tiny amount. Meanwhile, therapeutic effects are seen at microgram or nanogram levels. The massive dose gap means we have no idea what happens at actual therapeutic doses.

Practical Takeaways

If you're considering BPC 157, understand there's no solid proof it works or is safe

high confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.